Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: Caremark - The Real Truth

Eli Lilly Wins Back CVS Health, Reverting Novo's Advantage

Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy benefit manager CVS Health.

MarketBeat

Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away

Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new TrumpRx platform at steep discounts and extend "most favored nation" (MFN) pricing to Medicaid, Pfizer bought itself a…

Benzinga

This High-Yield Dividend Stock Is Staging a Comeback. Should You Buy Shares Now?

CVS Health’s blowout Q2 2025 results, boosted earnings guidance, and “Strong Buy” analyst consensus make it a standout comeback story among high-yield dividend stocks.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Mark Zuckerberg, Peter Thiel And Meta Board Dodge Courtroom Showdown As Shareholders Abruptly Settle $8 Billion Privacy Lawsuit

Meta Platforms, Inc. (NASDAQ:META) shareholders ended a landmark $8 billion lawsuit against Mark Zuckerberg and several current and former executives on Thursday, reaching a surprise settlement just as the high-profile privacy trial was set to enter its second day.

Benzinga

Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?

Shares of Eli Lilly just got walloped. So, is the company still the name to own in GLP-1s, or are the tables turning on this pharma giant?

MarketBeat

Why Karen Lynch lost the CEO job at CVS

A trifecta of problems, some that started before she took the top job, ended the reign of one of the most powerful women in American business.

Fortune

High insulin prices spur a federal lawsuit against three pharmacy benefit managers

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

CVS Health CTO tries to smooth over complexity to propel his company's big bet on healthcare

CTO Tilak Mandadi is juggling a complex business with many different units.

Fortune

Corporate Officers Face Expanded Oversight

Learn about the expanding personal liability of corporate officers for oversight failures in today's legal landscape.

Top News

No Sealing in Case Seeking to Enforce $17M Arbitration Award Related to Medicare Prescription Drug Benefits

From Judge Naomi Reice Buchwald's opinion Thursday in Caremark, L.L.C. v. N.Y. Cancer & Blood Specialists, Inc.: Petitioners Caremark, L.L.C., … SilverScript Insurance Company, and Aetna, Inc. seek to file their petition to vacate an arbitration award under seal; or, in the alternative, partially under seal; or, in the second…

Reason

Ikea, Aldi and Waitrose named in top 10 places to work in Merseyside and Wales

A jobs website rates these employers as the best and worst places to work

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations